Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2009 December;75(12) > Minerva Anestesiologica 2009 December;75(12):698-702

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA ANESTESIOLOGICA

Rivista di Anestesia, Rianimazione, Terapia Antalgica e Terapia Intensiva


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623


eTOC

 

EXPERTS’ OPINION  FREEfree


Minerva Anestesiologica 2009 December;75(12):698-702

Copyright © 2009 EDIZIONI MINERVA MEDICA

lingua: Inglese

What anesthesiologists should know about B-type natriuretic peptide

Noveanu M., Hartwiger S., Mueller C.

Department of Internal Medicine, University Hospital, Basel, Switzerland


FULL TEXT  


Natriuretic peptides (NPs), particularly B-type natriuretic peptide (BNP) and N-terminal pro BNP (NT-proBNP), are widely used as markers of cardiac wall stress and heart failure (HF) in daily clinical practice. The measurement of NPs became a part of national and international cardiovascular guidelines for the diagnosis and treatment of HF. NP measurement improves diagnosis and management and helps to predict outcome in patients presenting with acute dyspnea in the Emergency Department. Additionally, NPs are of special interest for anesthesiologists. This includes improved management of Intensive Care Unit patients with respiratory failure and preoperative risk assessment. This paper reviews and highlights the use of NPs in clinical practice focusing on issues that may be of particular interest to anesthesiologists.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

chmueller@uhbs.ch